Furthermore, correlation analysis of MEG3 expression with clinical pathological features of NSCLC patients, revealed a significant association between MEG3 downregulation and advanced pathological stage (I/II,37; IIIa/b,IV,7) and NSCLC tumor size (Figure 1B,C). Here, MEG3 is linked to neoplasm.